ServiceNow stock is the IBD Stock of the Day ahead of the enterprise software maker's fourth quarter earnings report.

Children who were diagnosed with inflammatory bowel disease (IBD) showed a decline in height, weight, and body mass index ...

The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second ...

A study suggests that adjunct therapies, including the Mediterranean diet, physical activity, and cognitive behavioral ...

Eating a Mediterranean-style diet can help people manage IBD symptoms, and a new cookbook from Crohn's & Colitis Ireland ...

Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...

The FDA expanded the approval of mirikizumab (Omvoh) to include treatment of adults with moderately to severely active ...

A new storage technique can keep protein-based drugs and vaccines stable without keeping them cold, potentially eliminating ...

Wearable devices can identify, differentiate, and predict flare-ups, or the worsening of symptoms and inflammation, in inflammatory bowel disease (IBD), Mount Sinai researchers have shown in a ...

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting ...

According to new research, wearables like an Apple Watch or an Oura smart ring can detect the symptoms and predict flare-ups ...